PORTLAND – The state is preparing further to limit access to costly, brand-name drugs for 210,000 Medicaid patients next month, a move that is designed to save $100 million over the next two years. Maine joins a growing number of private insurers and states in… Read More
Comments for: Maine Medicaid limits name-brand drugs
Maine Medicaid limits name-brand drugs
You may also like
Maine Medicaid limits name-brand drugs